Prospects for development of new antimicrobials for clinical control of tuberculosis. 2. Current status and perspectives on the development of rifamycin derivative antibiotics.
BLOOMFIELD, G. Tuberculosis, trends and opportunities. In Scrip Reports. 1995, 85-101
Health News Daily. 1998, 10, 121
TRAXLER, P. New rifamycins. Drugs of the future. 1988, 13, 845-856
BIRMINGHAM, AT. Antibacterial activity in serum and urine following oral adminiatration in man of DL473 (a cyclopentyl derivative of rifampicin). Br J Clin Pharmacol. 1978, 6, 455-456